Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Noa Krugliak Cleveland

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
Gastrointestinal Endoscopy|September 16, 2018
ResponseNoa Krugliak Cleveland, David T Rubin
The American Journal of Gastroenterology|April 8, 2015
Using a Treat-to-Target Management Strategy to Improve the Doctor-Patient Relationship in Inflammatory Bowel DiseaseDavid T Rubin, Noa Krugliak Cleveland
Practical Gastroenterology|October 28, 2021
CANCER PREVENTION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASENoa Krugliak Cleveland, David T Rubin
The American Journal of Gastroenterology|April 30, 2016
Safety and Efficacy of Live Measles Vaccine Administered to a Crohn's Disease Patient Receiving VedolizumabAlana Wichmann, Noa Krugliak Cleveland, David T Rubin
ACG Case Reports Journal|September 9, 2020
Hypersensitivity to IV Ustekinumab but Tolerance to Subcutaneous Ustekinumab in a Patient With Crohn's DiseaseNoa Krugliak Cleveland, Alexandra Masching, David T Rubin
Gastroenterology|August 14, 2022
A Summary of the BRIDGe Summit on Damage-Related Progression of Ulcerative Colitis: Establishing Research PrioritiesNoa Krugliak Cleveland, Brian Bressler, Corey A Siegel, et al.
Gastroenterology|February 1, 2022
What Does Disease Progression Look Like in Ulcerative Colitis, and How Might It Be Prevented?Noa Krugliak Cleveland, Joana Torres, David T Rubin
Gastrointestinal Endoscopy|November 19, 2016
Outcomes of colitis-associated dysplasia after referral from the community to a tertiary centerDavid T Rubin, Noa Krugliak Cleveland, Dylan M Rodriquez
ACG Case Reports Journal|November 22, 2019
Use of Tofacitinib for the Treatment of Arthritis Associated With Ulcerative ColitisWenfei Wang, Noa Krugliak Cleveland, Jacob Ollech, et al.
Gastroenterology & Hepatology|December 31, 2016
The Role of Biosimilars in Inflammatory Bowel DiseaseSudarshan Paramsothy, Noa Krugliak Cleveland, Nada Zmeter, et al.
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
Gastrointestinal Endoscopy|September 16, 2018
ResponseNoa Krugliak Cleveland, David T Rubin
The American Journal of Gastroenterology|April 8, 2015
Using a Treat-to-Target Management Strategy to Improve the Doctor-Patient Relationship in Inflammatory Bowel DiseaseDavid T Rubin, Noa Krugliak Cleveland
Practical Gastroenterology|October 28, 2021
CANCER PREVENTION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASENoa Krugliak Cleveland, David T Rubin
The American Journal of Gastroenterology|April 30, 2016
Safety and Efficacy of Live Measles Vaccine Administered to a Crohn's Disease Patient Receiving VedolizumabAlana Wichmann, Noa Krugliak Cleveland, David T Rubin
ACG Case Reports Journal|September 9, 2020
Hypersensitivity to IV Ustekinumab but Tolerance to Subcutaneous Ustekinumab in a Patient With Crohn's DiseaseNoa Krugliak Cleveland, Alexandra Masching, David T Rubin
Gastroenterology|August 14, 2022
A Summary of the BRIDGe Summit on Damage-Related Progression of Ulcerative Colitis: Establishing Research PrioritiesNoa Krugliak Cleveland, Brian Bressler, Corey A Siegel, et al.
Gastroenterology|February 1, 2022
What Does Disease Progression Look Like in Ulcerative Colitis, and How Might It Be Prevented?Noa Krugliak Cleveland, Joana Torres, David T Rubin
Gastrointestinal Endoscopy|November 19, 2016
Outcomes of colitis-associated dysplasia after referral from the community to a tertiary centerDavid T Rubin, Noa Krugliak Cleveland, Dylan M Rodriquez
ACG Case Reports Journal|November 22, 2019
Use of Tofacitinib for the Treatment of Arthritis Associated With Ulcerative ColitisWenfei Wang, Noa Krugliak Cleveland, Jacob Ollech, et al.
Gastroenterology & Hepatology|December 31, 2016
The Role of Biosimilars in Inflammatory Bowel DiseaseSudarshan Paramsothy, Noa Krugliak Cleveland, Nada Zmeter, et al.
Pageof 6